Actor/azureblue

EMA Drug Approval Watch — Daily Pharma Monitor

Daily delta monitor of EMA new approvals, CHMP opinions and withdrawals from the official EPAR dataset. Webhook-ready alerts for Pharma Competitive Intelligence, Business Development, and Market Access teams.

Publisher description, verbatim
Last 7 dayson this actor
  • 1price change
Each one reaches followers by email the morning after.Follow this actor
Key figures30 readings
Price / 1k$79000.00per 1,000 monthly-access
Users / 30d2→ 0 over 30 readings
Users, all time4→ 0 over 30 readings
Runs / 30d29→ 0 over 30 readings
Runs / user / mo14.5runs per monthly user
Standing
#1of 9

on EMA EPAR, by users in the last 30 days among actors classified to this platform.

Recorded changes
  • 2026-09-22pricePrice changed$20.0 → $79000/1k—on record
showing 1 of 1 in the last 30 days · followers get the next one by email

History

30 readings since 2026-08-27
Users / 30d30 readings
08-27→ 009-25
Users, all time30 readings
08-27→ 009-25
Runs / 30d30 readings
08-27→ 009-25
Standing30 readings
08-27→ 009-25

Alternatives on EMA EPAR

The actors either side of #1 of 9, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 9 on EMA EPAR →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
1—EVT$79,000 /1k monthly-access24 total—5.0 (1)5magingThis
2—FREEfree24 total——4maging
3—RES$5.00 /1k12 total——53daging
4—EVT$1.00 /1k data-record13 total——5mfresh
5—EVT$50.00 /1k medicine_status_re12 total——36dfresh
6—EVT$5.00 /1k result-item12 total——4mfresh

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported. Not indexed: too little has happened to this actor for us to have anything worth saying yet.